These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 13139438)
41. [Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine]. Nekliudova LI; Fedorova IuB; Orlova NG Vopr Virusol; 1974; (2):173-6. PubMed ID: 4446555 [No Abstract] [Full Text] [Related]
42. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Katayose M; Hosoya M; Haneda T; Yamaguchi H; Kawasaki Y; Sato M; Wright PF Vaccine; 2011 Feb; 29(9):1844-9. PubMed ID: 21195802 [TBL] [Abstract][Full Text] [Related]
43. Cell-based protein vaccines for influenza. Cox MM Curr Opin Mol Ther; 2005 Feb; 7(1):24-9. PubMed ID: 15732526 [TBL] [Abstract][Full Text] [Related]
45. The use of inactivated influenza vaccine in children. Wright PF Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371 [TBL] [Abstract][Full Text] [Related]
46. The response to influenza vaccines as determined by levels of complement-fixing antibody in the acute-phase sera of patients with respiratory disease. CULVER JO; LENNETTE EH; NAVARRE G; KEMPE CH J Immunol; 1960 Jan; 84():98-105. PubMed ID: 13813266 [No Abstract] [Full Text] [Related]
47. Influenza DNA vaccine: an update. Chen Z Chin Med J (Engl); 2004 Jan; 117(1):125-32. PubMed ID: 14733788 [No Abstract] [Full Text] [Related]
48. Use of cold-adapted live attenuated influenza vaccine in pediatric patients. Bender WJ S D J Med; 2005 Dec; 58(12):497-8. PubMed ID: 16700351 [No Abstract] [Full Text] [Related]
49. Influenza vaccine safety in patients with egg allergy. Croegaert KA; Ithman MM; Spurgin AL; Vos SS; Milavetz G J Am Pharm Assoc (2003); 2013; 53(2):214-6. PubMed ID: 23571631 [No Abstract] [Full Text] [Related]
50. [Concern about vaccination: which vaccine in the event of pandemic influenza?]. Snacken R; Maes S Rev Med Brux; 2006; 27(2):75-6. PubMed ID: 16736843 [No Abstract] [Full Text] [Related]
51. [Influenza vaccine and influenza vaccination]. Flugsrud L; Nøkleby H Tidsskr Nor Laegeforen; 1992 Oct; 112(26):3291-2. PubMed ID: 1471101 [No Abstract] [Full Text] [Related]
52. The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity. POLLEY JR; GUERIN MM Can J Microbiol; 1957 Oct; 3(6):871-7. PubMed ID: 13472512 [No Abstract] [Full Text] [Related]
53. [Universal influenza vaccine still far in the future]. Rimmelzwaan GF; Osterhaus AD Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2305-7. PubMed ID: 10589217 [TBL] [Abstract][Full Text] [Related]
54. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP; Bichurina MA; Rozaeva NR Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
55. [Research progress and prospect of universal influenza vaccine]. Luo DY; Xue CY; Cao YC Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771 [TBL] [Abstract][Full Text] [Related]
57. Influenza: a case for an improved link between vaccine research and public health. Palache AM Immunol Lett; 2009 Feb; 122(2):137. PubMed ID: 19100772 [No Abstract] [Full Text] [Related]
60. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Fry AM; Kim IK; Reed C; Thompson M; Chaves SS; Finelli L; Bresee J Clin Infect Dis; 2014 Aug; 59(3):406-9. PubMed ID: 24803379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]